Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Alcobra Ltd (ADHD)’

10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

Alcobra Ltd (ADHD): Here’s Our Take

Alcobra Ltd (NASDAQ:ADHD) lost more than 50% of its market capitalization during Tuesday’s session, and ahead of the market open on Wednesday, is down......(read more)

RA Capital Management Slashes Alcobra Ltd (ADHD) Position After FDA Clinical Hold

Peter Kolchinsky‘s RA Capital Management has slashed its position in Alcobra Ltd (NASDAQ:ADHD) to just under 1.31 million shares according to a......(read more)

Here’s Why These Five Stocks Are in the Spotlight Today

Volatility is low and the markets are quiet today, although three major indexes are trading in the red. In this article, we will analyze five stocks that......(read more)

Two Activist Plays And Two Biotech Moves You Should Check Out

With hedge funds having submitted their 13F filings for the third quarter, people at Insider Monkey are busy compiling the data necessary to identify......(read more)

RA Capital’s Latest Move In Alcobra Ltd (ADHD) Coming Off Hefty Second Quarter Gains

According to a recent filing with the Securities and Exchange Commission, Peter Kolchinsky‘s RA Capital has initiated a position in Alcobra Ltd (......(read more)
Jeffrey Ray - Great Point Partners

Jeffrey Ray’s Great Point Partners Trims Its Stake In Alcobra Ltd (ADHD)

Jeffrey Jay and David Kroin’s healthcare-focused fund, Great Point Partners, decreased its passive stake in the Israel based biopharmaceutical......(read more)
Broadfin Kevin Kotler

Epirus Biopharmaceuticals Inc (EPRS): These Two Funds Open New Positions

The days of having no fund activity in Epirus Biopharmaceuticals Inc (NASDAQ:EPRS) are over. In filings with the SEC that were revealed over the last......(read more)
Broadfin Kevin Kotler

Alcobra Ltd (ADHD): Broadfin Capital and Deerfield Initiate Passive Stakes Following Public Offering

Kevin Kotler’s Broadfin Capital and James Flynn’s Deerfield Management have both initiated passive stakes in Alcobra Ltd (NASDAQ:ADHD). As......(read more)